Literature DB >> 33835685

Classification and analysis of outcome predictors in non-critically ill COVID-19 patients.

Sergio Venturini1, Daniele Orso2,3, Francesco Cugini4, Massimo Crapis1, Sara Fossati1, Astrid Callegari1, Tommaso Pellis5, Maurizio Tonizzo6, Alessandro Grembiale6, Alessia Rosso6, Mario Tamburrini7, Natascia D'Andrea2,3, Luigi Vetrugno2,3, Tiziana Bove2,3.   

Abstract

BACKGROUND: Early detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-infected patients who could develop a severe form of COVID-19 must be considered of great importance to carry out adequate care and optimise the use of limited resources. AIMS: To use several machine learning classification models to analyse a series of non-critically ill COVID-19 patients admitted to a general medicine ward to verify if any clinical variables recorded could predict the clinical outcome.
METHODS: We retrospectively analysed non-critically ill patients with COVID-19 admitted to the general ward of the hospital in Pordenone from 1 March 2020 to 30 April 2020. Patients' characteristics were compared based on clinical outcomes. Through several machine learning classification models, some predictors for clinical outcome were detected.
RESULTS: In the considered period, we analysed 176 consecutive patients admitted: 119 (67.6%) were discharged, 35 (19.9%) dead and 22 (12.5%) were transferred to intensive care unit. The most accurate models were a random forest model (M2) and a conditional inference tree model (M5) (accuracy = 0.79; 95% confidence interval 0.64-0.90, for both). For M2, glomerular filtration rate and creatinine were the most accurate predictors for the outcome, followed by age and fraction-inspired oxygen. For M5, serum sodium, body temperature and arterial pressure of oxygen and inspiratory fraction of oxygen ratio were the most reliable predictors.
CONCLUSIONS: In non-critically ill COVID-19 patients admitted to a medical ward, glomerular filtration rate, creatinine and serum sodium were promising predictors for the clinical outcome. Some factors not determined by COVID-19, such as age or dementia, influence clinical outcomes.
© 2021 Royal Australasian College of Physicians.

Entities:  

Keywords:  COVID-19; machine learning; non-critically ill; prediction

Year:  2021        PMID: 33835685     DOI: 10.1111/imj.15140

Source DB:  PubMed          Journal:  Intern Med J        ISSN: 1444-0903            Impact factor:   2.048


  4 in total

1.  Mental and neurological disorders and risk of COVID-19 susceptibility, illness severity and mortality: A systematic review, meta-analysis and call for action.

Authors:  Lin Liu; Shu-Yu Ni; Wei Yan; Qing-Dong Lu; Yi-Miao Zhao; Ying-Ying Xu; Huan Mei; Le Shi; Kai Yuan; Ying Han; Jia-Hui Deng; Yan-Kun Sun; Shi-Qiu Meng; Zheng-Dong Jiang; Na Zeng; Jian-Yu Que; Yong-Bo Zheng; Bei-Ni Yang; Yi-Miao Gong; Arun V Ravindran; Thomas Kosten; Yun Kwok Wing; Xiang-Dong Tang; Jun-Liang Yuan; Ping Wu; Jie Shi; Yan-Ping Bao; Lin Lu
Journal:  EClinicalMedicine       Date:  2021-09-08

2.  Home management of COVID-19 symptomatic patients: a safety study on COVID committed home medical teams.

Authors:  Sergio Venturini; Daniele Orso; Francesco Cugini; Francesco Martin; Cecilia Boccato; Laura De Santi; Elisa Pontoni; Silvia Tomasella; Fabrizio Nicotra; Alessandro Grembiale; Maurizio Tonizzo; Silvia Grazioli; Sara Fossati; Astrid Callegari; Giovanni Del Fabro; Massimo Crapis
Journal:  Infez Med       Date:  2022-09-01

Review 3.  Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Abraham Degarege; Zaeema Naveed; Josiane Kabayundo; David Brett-Major
Journal:  Pathogens       Date:  2022-05-10

4.  Chromogranin A plasma levels predict mortality in COVID-19.

Authors:  Rebecca De Lorenzo; Clara Sciorati; Giuseppe A Ramirez; Barbara Colombo; Nicola I Lorè; Annalisa Capobianco; Cristina Tresoldi; Daniela M Cirillo; Fabio Ciceri; Angelo Corti; Patrizia Rovere-Querini; Angelo A Manfredi
Journal:  PLoS One       Date:  2022-04-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.